AgelessRx presents its injection program as an ongoing relationship with a care team, with monthly and three-month plan options. The eye-catching $99 figure is a first-month promotion. Its published condition ties that offer to a three-month plan paid in full, with $149 per month listed afterward.
This Second Look review examines the public offer and the full financial commitment. CoreAge Rx is this publication’s featured commercial partner and appears first in our shortlists. That placement does not establish that another provider is clinically inferior. We reviewed public material; we have not purchased treatment, audited the pharmacy, or collected comparable patient outcome data.
AgelessRx may interest someone comparing a program with published messaging and adjustment features. The practical tradeoff is understanding the prepaid commitment before choosing the introductory offer.
An introductory rate with a longer billing commitment
The billing condition is central to this offer. Treat the first-month price, total collected today, and future rate as three separate numbers. We would not calculate a guaranteed checkout total from the headline alone, because promotional eligibility and the selected plan can change what appears at payment. Save the actual order summary before accepting a recurring arrangement. The provider's own page is the source of the advertised terms recorded here, checked September 21, 2026. Offers can change after that date.
Published offer: $99 first month. Intro offer on a three-month plan billed in full; page lists $149/month afterward. Use our cost guide to distinguish an introductory figure from an ongoing commitment. A promotional starting price should never stand in for the complete amount you authorize.
What the service description tells us
The injection page describes clinician-guided care, messaging, protocol adjustments, and US-licensed compounding pharmacy dispensing. It also describes ongoing check-ins. These are service features the company advertises, rather than a measured response-time or clinical-quality guarantee. Ask whether a medical message reaches the same clinician and what follow-up is included for your selected plan. The public description gives a starting point for questions; it does not establish a measured standard of care. State availability, clinician eligibility decisions, pharmacy assignment, and the final prescription should be confirmed for your own situation.
A useful review follows responsibility through the whole process. Ask for the prescribing practice's name, the clinician responsible for follow-up, and the dispensing pharmacy's contact details. The pharmacy checklist explains why those organizations may be different from the name on the website.
The claim that deserves a second look
AgelessRx also discusses other delivery formats elsewhere on its site. Our reviewed offer is the injection page. Evidence concerning injected medication cannot be transferred automatically to a nasal preparation, and a product switch should prompt a fresh conversation about absorption, dosing directions, clinical goals, and price. The Endocrine Society's guidance on adult growth hormone deficiency concerns a defined diagnosis. It should not be taken as an endorsement of sermorelin for every person experiencing normal aging.
Our benefits and evidence guide separates studies of the exact drug from research about a related hormone pathway. Ask which findings apply to the proposed formulation and your intended outcome. A laboratory change and a meaningful improvement in everyday life are different claims.
A conversation to have before paying
Start with this provider-specific question: What is the full three-month charge, when does the promotional rate end, and how do I stop the next renewal? Request the answer in writing along with the selected product, the first charge, and the renewal date. If a detail is not available on the sales page, treat it as unresolved rather than assuming it is included or free.
Then discuss why treatment is being considered. Describe the problem in practical terms, such as when tiredness occurs or how sleep has changed, and provide your complete health history. Our consultation questions cover alternatives, monitoring, and what happens when a clinician decides not to prescribe.
Safety, pharmacy, and follow-up
Compounded sermorelin is not FDA-approved. The FDA explains that compounded preparations do not undergo its premarket review for safety, effectiveness, and quality. That distinction applies to AgelessRx and to our featured partner alike.
Discuss allergies, tumor or cancer history, pituitary or other endocrine conditions, glucose concerns, pregnancy or breastfeeding where relevant, and all medicines and supplements. The side-effect guide provides general context, but the prescriber must assess your circumstances. Severe reactions such as difficulty breathing or face or throat swelling require emergency care.
If a prescription is issued, ask the pharmacist to reconcile the concentration, prescribed amount, supplied device, storage directions, and beyond-use date. Never copy another person's syringe markings. Ask how to obtain help with a damaged or delayed shipment and which medical contact is available after the initial visit.
Who may find this option worth investigating
AgelessRx may interest someone comparing a program with published messaging and adjustment features. The practical tradeoff is understanding the prepaid commitment before choosing the introductory offer. We would pause the purchasing decision if the exact preparation, medical follow-up, or recurring bill remained unclear. Those are answerable questions, not reasons to substitute an unsupported star rating.
Before making a shortlist, compare the other reviewed services and the online-provider comparison. Keep a copy of the offer and the answers you received. A sound decision can end with a different service, further evaluation, or no treatment; the point is to understand the choice before making the commitment.
The source notes
Sources & further reading
Provider pages document advertised offers, not independently proven outcomes. Historical references may concern different products or uses. Sources were checked for this edition on September 21, 2026; offers can change.